beraprost: Clinical Trials

3 trials of beraprost, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Withdrawn 1

Follow beraprost: new trials by email Literature Review of beraprost trials Research Report on beraprost

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension
Esuberaprost, Placebo - Pulmonary Arterial Hypertension
Phase 3TerminatedLung Biotechnology PBC1122018-12-102020-09-07
Beraprost-314d Added-on to Tyvaso® (BEAT)
Beraprost Sodium 314d Modified Release Tablets, Placebo - Pulmonary Arterial Hypertension
Phase 3CompletedLung Biotechnology PBC2732013-05-312020-08-03
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
Beraprost Sodium 314d Modified Release Tablets, Placebo - Pulmonary Arterial Hypertension
Phase 3WithdrawnLung Biotechnology PBC2011-11-012012-05-14

Conditions studied

Pulmonary Arterial Hypertension (3)  ·  Cardiovascular Diseases (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Hypertension (1)  ·  Hypertension, Pulmonary (1)  ·  Lung Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Vascular Diseases (1)

Sponsors

Lung Biotechnology PBC (3)

Countries

Israel (2)  ·  United States (2)